Additional studies are required to identify whether IL-17 is involved in the pathogenesis of AA, PRP, pemphigus, and SSc, which may lead to the development of targeted strategies for efficiently ameliorating or specifically eliminating these debilitating diseases. Here, IL17A is linked to systemic sclerosis.